DEK and breast cancer: Recent reports have shown that transcription of the DEK oncogene is up-regulated in breast cancers with particularly strong gene expression detected in lymph node positive and late stage breast cancers, and that DEK expression correlated with increased recurrence rates after 3 years [3]–[6].